American Society Of Hematology Recent News
Celgene's Lymphoma Strategy Is Its Biggest Positive, Analyst Says
Vetr Upgrades Alnylam On News Of Streamed Press Conference
Biotech Winners And Losers From ASH Conference
8 Of The Biggest Biotech Announcements Out Of The 2016 ASH Meeting
A Primer On Endpoints: Global Blood Therapeutics
UniQure Vs. Spark Therapeutics: One Has Better Timing, The Other Has Better Efficacy
What Is The ASH Conference And Why Should Biotech Investors Care?
Exclusive: SunTrust Managing Director Discusses Bluebird Bio, A Leader In Gene Therapy
One Way To Bet On The American Society Of Hematology's Meeting Next Month
Jefferies Maintains Buy, $6 Target on Array BioPharma
Five Biotech Stocks to Watch Going into Big Doctors' Meeting